Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Poland

 

Fremman buys Stingray to merge with Amethyst

Two of Europe’s three largest private oncology groups are being merged into a single entity, creating continental Europe’s largest oncology player. Private equity firm Fremman Capital has acquired Stingray, an oncology group with a presence in France and Germany, to merge it with its portfolio company Amethyst, a major pan-European radiotherapy group which already has a presence in seven European countries.
November 6, 2025

Revenue distribution of top 100 hospital groups in EMEA by country

This week’s infographic aggregates the 2024 total revenues of the top 100 hospital groups across Europe, the Middle East, and Africa, segmented by country, exposing distinct concentrations of market size and investment intensity.  The data has been sourced from the HBI Intelligence database. Germany commands a dominant position with €22.6 billion in hospital revenues, over […]
September 18, 2025

Ribera Salud enters Poland

Spanish hospital group Ribera Salud has entered the Polish market. It has bought a small imaging and outpatient chain in Warsaw called Multi Med.
September 11, 2025

FREE BLOG Election season in Poland — what might it mean for the private health sector?

The ongoing elections in Poland, with both candidates competing neck and neck, are expected to have major consequences for the country’s health system — but not necessarily in the way one might expect. Liberal Warsaw mayor Rafał Trzaskowski, part of Prime Minister Donald Tusk’s Civic Platform, narrowly won the first round on 18 May with […]
May 29, 2025

Mehiläinen acquires Regina Maria and MediGroup, signalling growing investor confidence in CEE

Mehiläinen, Finland’s largest for-profit healthcare group, backed by Luxembourg-based CVC Capital Partners, has acquired Romania’s Regina Maria and Serbia’s MediGroup from private equity firm MidEuropa. The deal, which is said to be the largest ever healthcare services transaction in Central Europe, is pending regulatory approval and is expected to close later this year.
April 3, 2025

Diagnostyka IPO launches

Diagnostyka, Poland’s largest for-profit laboratory provider, has become a public company after listing on the Warsaw Stock Exchange.
February 7, 2025

Poland’s private healthcare poised for growth as Diagnostyka plans IPO

Diagnostyka, Poland's largest private diagnostic laboratory provider, plans to list on the Warsaw Stock Exchange, hoping to achieve a $1.2 billion valuation. The IPO will involve the sale of shares by private equity firm MidEuropa, which currently backs Diagnostyka, holding a 47.83% stake. Diagnostyka’s founders, key management, and board members will retain their shares, and the company will not issue new ones. A portion of the offering, between 5 - 10%, will be allocated to retail investors, according to a press release.
January 17, 2025

Interview: Stéphane Carré, Amethyst Radiotherapy Group

In this interview Stéphane Carré, CEO of pan-European radiotherapy provider Amethyst Radiotherapy, explains how his company is aiming to increase access to state of the art radiotherapy services, and provide a holistic care journey geared towards making the patient feel as comfortable as possible. Stéphane Carré will be sharing more about his business model at HBI 2025, in Paris, March 24-26, 2025.
October 25, 2024
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us